Your browser doesn't support javascript.
loading
Recombinant receptor activator of nuclear factor κB exhibits more marked inhibitory effects on osteoclasts compared with recombinant osteoprotegerin in vitro and in vivo.
Xiong, Qi; Xin, Lingli; Zhang, Licheng; Tang, Peifu; Zhang, Lihai.
Afiliación
  • Xiong Q; Department of Orthopedics, General Hospital of Chinese PLA, Beijing 100853, P.R. China.
  • Xin L; Department of Obstetrics and Gynecology, The Second Artillery General Hospital of Chinese PLA, Beijing 100088, P.R. China.
  • Zhang L; Department of Orthopedics, General Hospital of Chinese PLA, Beijing 100853, P.R. China.
  • Tang P; Department of Orthopedics, General Hospital of Chinese PLA, Beijing 100853, P.R. China.
  • Zhang L; Department of Orthopedics, General Hospital of Chinese PLA, Beijing 100853, P.R. China.
Mol Med Rep ; 12(1): 631-8, 2015 Jul.
Article en En | MEDLINE | ID: mdl-25738879
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Osteoporosis / Proteínas Recombinantes / Receptor Activador del Factor Nuclear kappa-B / Osteoprotegerina Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Mol Med Rep Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Osteoporosis / Proteínas Recombinantes / Receptor Activador del Factor Nuclear kappa-B / Osteoprotegerina Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Mol Med Rep Año: 2015 Tipo del documento: Article